TENAX THERAPEUTICS, INC. - TENX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | — | P | A | 53,000.0 | 1.92 | 101,760.0 | 55,274.0 | View | |
| Sep 15, 2026 | CEO | P | A | 4,850.0 | 1.8221 | 8,837.19 | 22,174.0 | View | |
| Sep 15, 2026 | CEO | P | A | 6,000.0 | 1.875 | 11,250.0 | 17,324.0 | View | |
| Sep 15, 2026 | Chief Financial Officer | P | A | 5,675.0 | 1.935 | 10,981.13 | 15,675.0 | View | |
| Sep 08, 2026 | — | P | A | 900,000.0 | 1.7824 | 1,604,160.0 | 6,524,151.0 | View | |
| Sep 02, 2026 | — | P | A | 187,704.0 | 1.7985 | 337,585.64 | 5,624,151.0 | View | |
| Sep 02, 2026 | — | P | A | 179,058.0 | 1.7959 | 321,570.26 | 5,436,447.0 | View | |
| Sep 02, 2026 | — | P | A | 403,571.0 | 1.7905 | 722,593.88 | 5,257,389.0 | View | |
| Aug 24, 2026 | — | P | A | 107,374.0 | 1.7542 | 188,355.47 | 4,853,818.0 | View | |
| Aug 24, 2026 | — | P | A | 716,369.0 | 1.7676 | 1,266,253.84 | 4,746,444.0 | View | |
| Aug 24, 2026 | — | P | A | 202,124.0 | 1.7788 | 359,538.17 | 4,030,075.0 | View | |
| Jul 14, 2026 | CEO | M | D | 8,500.0 | 0.0 | 0.0 | 1,241,500.0 | View | |
| Jul 14, 2026 | CEO | M | D | 219.0 | 0.0 | 0.0 | 218.0 | View | |
| Jul 14, 2026 | CEO | M | A | 8,500.0 | 5.94 | 50,490.0 | 11,324.0 | View | |
| Jul 14, 2026 | CEO | M | A | 219.0 | 3.549 | 777.23 | 2,824.0 | View | |
| May 13, 2026 | Chief Financial Officer | A | A | 450,000.0 | 0.0 | 0.0 | 450,000.0 | View | |
| May 13, 2026 | Chief Financial Officer | A | A | 10,000.0 | 0.0 | 0.0 | 10,000.0 | View |